Hepion Pharmaceuticals

Hepion Pharmaceuticals, formerly ContraVir, Ciclofilin & Isotechnika, is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection (HBV, HCV, HDV).

Year Established: 2013 Stock Ticker: HEPA Exchange: NASDAQ

Locations

  • Hepion Pharmaceuticals

     Edmonton AB

    Hepion Pharmaceuticals, formerly ContraVir, Ciclofilin & Isotechnika, is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection (HBV, HCV, HDV).

  • Hepion Pharmaceuticals

     Edison NJ

    Hepion Pharmaceuticals, formerly ContraVir, Ciclofilin & Isotechnika, is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection (HBV, HCV, HDV).